wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36811453-3A57EE7E-165B-4212-975C-41E5056E7CE5
Q36811453-3A57EE7E-165B-4212-975C-41E5056E7CE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36811453-3A57EE7E-165B-4212-975C-41E5056E7CE5
Personalizing therapy in advanced non-small cell lung cancer
P2860
Q36811453-3A57EE7E-165B-4212-975C-41E5056E7CE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36811453-3A57EE7E-165B-4212-975C-41E5056E7CE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82782af7dbfe319e0d7febfa98bd506968411558
P2860
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer.